ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Auto-immunity"

  • Abstract Number: 020 • 2020 Pediatric Rheumatology Symposium

    Murine Roseolovirus Induces Autoimmune Disease and Development of Autoantibodies

    Tarin Bigley1 and Wayne Yokoyama 2, 1Washington University in St. Louis, Saint Louis, Missouri, 2Washington University in St. Louis, St Louis, Missouri

    Background/Purpose: Murine roseolovirus (MRV) is a recently sequenced beta-herpesvirus that is a natural murine pathogen and is genetically highly related to HHV6 and HHV7. The…
  • Abstract Number: 975 • 2019 ACR/ARP Annual Meeting

    Functional Impairment of Mitf and the MiT Transcription Factor Family Dysregulates B Cell Activation and Function

    Abhimanyu Amarnani1, Ramile Dilshat 2, Nikita Malakhov 3, Brian Ghezelaiagh 4, Chongmin Huan 1, Erna Magnusdottir 2, Eirikur Steingrimsson 2 and Christopher Roman 1, 1SUNY Downstate Medical Center, Brooklyn, 2University of Iceland Biomedical Center, Reykjavik, Iceland, 3SUNY Downstate Medical Center, New York Presbyterian-Weill Cornell Medical Center, Brooklyn, 4SUNY Downstate Medical Center, Stony Brook University, Brooklyn

    Background/Purpose: Autoreactive B cells are central in the development of many autoimmune diseases, such as systemic lupus erythematosus (SLE), and are normally eliminated or inactivated…
  • Abstract Number: 1810 • 2019 ACR/ARP Annual Meeting

    Rheumatic Toxicities Associated with Immune Checkpoint Inhibitors: An Observational, Retrospective, Pharmacovigilance Study

    Céline Anquetil1, Olivier Benveniste 1, Javid ‎ Moslehi 2, Douglas Johnson 2, Bénédicte lebrun-vignes 1, Olivier Lambotte 3, Joe-Elie Selam 4, Jean-Philippe Spano 5 and Yves Allenbach 1, 1Sorbonne Université, Paris, France, 2Vanderbilt, Nashville, 3APHP Médecine Interne/Immunologie Clinique, Hôpital Bicêtre, Paris, France. Université Paris Sud 11 – INSERM U1184 - CEA, Immunology of Viral Infections and Autoimmune Diseases, IDMIT Department, IBFJ, Fontenay-aux-Roses & Le Kremlin-Bicêtre, France., Paris, France, 4Sorbonne université, Paris, 5Sorbonne Université, Paris, French Guiana

    Background/Purpose: Monoclonal antibodies targeting co-inhibitory immune checkpoints (PD-1/PDL1 axis or CTLA-4) showed unprecedented clinical activity in several types of cancer by restoring antitumor immune responses.…
  • Abstract Number: 2618 • 2019 ACR/ARP Annual Meeting

    Anti-RNPC-3 Antibodies Are Associated with Nuclear Speckled Immunofluorescence Pattern and Enriched in Triple Negative Systemic Sclerosis Patients

    Michael Mahler1, Fabrece Roup 1, Chelsea Bentow 1, Marie Hudson 2, Murray Baron 3, May Choi 4 and Marvin Fritzler 5, 1Inova Diagnostics, San Diego, CA, 2Jewish General Hospital, Lady Davis Institute for Medical Research, and Department of Medicine, McGill University, Montreal, QC, Canada, 3Jewish General Hospital, McGill University, Montreal, Canada, 4Cumming School of Medicine, University of Calgary, Calgary, Canada, 5Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Anti-nuclear antibodies (ANA) are present in approximately 90% of sera from systemic sclerosis (SSc) patients and play an important diagnostic and prognostic role in…
  • Abstract Number: L07 • 2018 ACR/ARHP Annual Meeting

    VIB4920, a Novel, Engineered CD40L Antagonist Decreased Disease Activity and Improved Biomarkers of Immune Activation in Patients with Active Rheumatoid Arthritis in a Phase 1b, Multiple-Ascending Dose Proof-of-Concept Study

    Marius Albulescu1, Ulf Müller-Ladner2, Rachel Moate3, Kate Middleton3, Liangwei Wang4, Jorn Drappa4 and Gabor Illei5, 1Clinical Development, MedImmune, Cambridge, UK, Cambridge, United Kingdom, 2Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Germany, Bad Nauheim, Germany, 3MedImmune, Cambridge, UK, Cambridge, United Kingdom, 4Viela Bio, Gaithersburg, USA, Gaithersburg, MD, 5Viela Bio, Gaithersburg, USA, Gaithersberg, MD

    Background/Purpose: The CD40L/CD40 co-stimulatory pathway is important for T-cell-dependent antibody production and plays a central role in RA and other autoimmune diseases. VIB4920 (formerly  MEDI4920)…
  • Abstract Number: 2093 • 2018 ACR/ARHP Annual Meeting

    Glucocorticoid-Induced Leucine Zipper (GILZ) Deficiency Worsens Autoimmunity in the Lyn-Deficient Murine Model of Lupus By Disinhibiting the Type I Interferon (IFN) Pathway

    Champa Nataraja1, Eric Morand1, Jacinta Lee1, Taylah Bennett1, Jacqueline Flynn1, James Harris1 and Sarah Jones2, 1Medicine, School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia, 2School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia

    Background/Purpose: Systemic lupus erythematosus (SLE) is a multi-system autoimmune disease associated with B cell hyperactivity driven by dysregulated type I IFN. Lyn-deficient mice develop lupus-like…
  • Abstract Number: 2932 • 2018 ACR/ARHP Annual Meeting

    Systemic Lupus Erythematosus Biomarkers Identified Using Multi-Omic and Artificial Intelligence Analysis through Interrogative Biology

    Eric Grund1, Lixia Zhang1, Leonardo Rodrigues1, Viatcheslav Akmaev1, Rangaprasad Sarangarajan1, Michael Kiebish1, Niven Narain1 and Gary S. Gilkeson2, 1BERG, LLC, Framingham, MA, 2Department of Medicine, Medical University of South Carolina, Charleston, SC

    Background/Purpose: Biomarkers for use in developing treatments and diagnostics for Systemic Lupus Erythematosus (SLE) are a large unmet need. The wide differential in patient progression…
  • Abstract Number: 3 • 2018 ACR/ARHP Annual Meeting

    Interferon-Alpha Disrupts DNA-Specific B Cell Tolerance in 3H9 Mice

    Dario Ferri1, Yuriy Baglaenko2, Ariana Karanxha1, Kieran Manion1, Carolina Grajales1 and Joan E. Wither1, 1Genetics and Development, Krembil Research Institute, University Health Network, Toronto, ON, Canada, 2Department of Biomedical Informatics, Brigham Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: A central mediator of Systemic Lupus Erythematosus (SLE) pathogenesis is interferon-alpha (IFNα), which is elevated in the serum of SLE patients. IFNα has been…
  • Abstract Number: 5 • 2018 ACR/ARHP Annual Meeting

    Short Chain Fatty Acid Acetate Induces Regulatory B Cells in Mice and Humans, Which Can Protect Against Arthritis

    Claire I. Daien1,2,3, Julie Mielle1,4, Rachel Audo1,2,5, Lake-Ee Quek1, James Krycer1, Gauthier Rathat6, Gabriela Pinget1, Sumaiya Hoque7, Charles Mackay8, Jian Tan9 and Laurence Macia1, 1Charles Perkins Centre, The University of Sydney, Sydney, Australia, 2IGMM, CNRS UMR5535, Montpellier, Montpellier, France, 3Department of rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 4IGMM CNRS UMR5535, Montpellier, France, 5Rheumatology, Lapeyronie Hospital and Montpellier University, Montpellier, France, 6Arnaud-de-Villeneuve Hospital, Montpellier, France, 7Charles Perkins Centre, The University of Sydney, Sydney, France, 8Monash University, Melbourne, Australia, 9Charles Perkins Centre, The University of Sydney, Montpellier, Australia

    Background/Purpose: Autoimmunity and more broadly non-communicable diseases develop with the imbalance between anti- and pro-inflammatory immune cell subsets, leading to an uncontrolled and damaging inflammation.…
  • Abstract Number: 142 • 2018 ACR/ARHP Annual Meeting

    Peripheral CD4+CD25+Foxp3+T Regulatory Cells Absolutely Reduce in Patients with Systemic Lupus Erythematosus

    Xiao-Qing Liu1, Na-Lin Lai2, Yanan Duan1, Junwei Chen1, Xiao-Feng Li3 and Chong Gao4, 1The Second Hospital of Shanxi Medical University, Taiyuan, China, 2Rheumatology, The Second Hospital of Shanxi Medical University, Taiyuan, China, 3Rheumatology, the Second Hospital of Shanxi Medical University, Taiyuan, China, 4Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Cambridge, MA

    Background/Purpose: Regulatory T (Treg) cells, with the capacity to suppress immune responses, and effector T (Teff) cells, to promote inflammation, have been intensively studied in…
  • Abstract Number: 1382 • 2018 ACR/ARHP Annual Meeting

    Evaluating Results of an Interferon-γ Release Assay in Patients with Autoimmune Skin Disease on Hydroxychloroquine

    Rebecca Gaffney1 and Victoria P. Werth2, 1Dermatology, University of Pennsylvania, Philadelphia, PA, 2Department of Dermatology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: QuantiFERON-TB Gold is commercial interferon-γ release assay used to screen patients for tuberculosis before starting or while on immunosuppressive therapies. Clinical studies on efficacy…
  • Abstract Number: 1968 • 2018 ACR/ARHP Annual Meeting

    eQTL Analysis of More Than 1000 Human Blood Samples Reveals Shared and Unique Signals across Seven Systemic Autoimmune Diseases : The Precisesads Project

    Martin Kerick1, David Gonzalez Serna1, Elena Carnero-Montoro2, Sepideh Babaei3, Marialbert Acosta-Herrera1, Maria Teruel2, Guillermo Barturen2, Zuzanna Makowska3, Anne Buttgereit4, Sikander Hayat4, Jorge Kageyama4, Manuel Martínez-Bueno2, PRECISESADS Clinical Consortium5, Ralf Lesche3, Javier Martin6 and Marta Alarcón-Riquelme2, 1Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain, 2Medical Genomics, Center for Genomics and Oncological Research (GENYO), Granada, Spain, 3Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany, 4Bayer Pharma Aktiengesellschaft, Berlin, Germany, 5Spain, 6Instituto de Parasitología y Biomedicina ‘López-Neyra’, CSIC, PTS Granada, Granada, Spain., Granada, Spain

    Background/Purpose: Systemic autoimmune diseases (SADs) are chronic inflammatory conditions with autoimmune aetiology and many common clinical features, hampering diagnosis and adequate treatment decisions. Finding new…
  • Abstract Number: 295 • 2017 ACR/ARHP Annual Meeting

    Ex Vivo Induced Neutrophil Extracellular Traps Are Intrinsically Different in Anca-Associated Vasculitis and Systemic Lupus Erythematosus

    Laura van Dam1, Tineke Kraaij1, Sylvia Kamerling1, Hans U. Scherer2, Charles Pusey3, Ton Rabelink1, Cees van Kooten1 and Onno Teng1, 1Nephrology, Leiden University Medical Center, Leiden, Netherlands, 2Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 3Imperial College, London, United Kingdom

    -          Background/Purpose: Neutrophil extracellular traps (NETs) are immunogenic, extracellular DNA structures that harness important autoantigens to be recognized by the adaptive immune system. NETs are…
  • Abstract Number: 492 • 2017 ACR/ARHP Annual Meeting

    Is Leukotoxin_A Produced By Aggregatibacter Actynomycetemcomitans Important for Initiating Autoimmune Responses Underlying Rheumatoid Arthritis?

    Mikhail Volkov1, Jacqueline Dekkers1, Bruno G. Loos2, Sergio Bizzarro2, Tom W.J. Huizinga3, Helle A. Praetorius4, Rene E.M. Toes5 and Diane van der Woude1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Periodontology, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit, Amsterdam, Netherlands, 3Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 4Department of Biomedicine, Aarhus University, Aarhus, Denmark, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: In a recent publication in Science Translational Medicine, Konig et al. (2016) describe a potential explanation for the link between periodontal infection and RA.…
  • Abstract Number: 562 • 2017 ACR/ARHP Annual Meeting

    Anti-Muscarinic Receptor 3 Antibodies – a Cross Reactive Result of Ro60 Immunization

    Syed M.S. Quadri1, Biji T Kurien2, Kristi A. Koelsch3 and R. Hal Scofield4, 1Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Arthritis and Clinical Immunology Program, Oklahoma Medical Research Foundation, Okalahoma City, OK, 4Oklahoma Medical Research Foundation, Oklahoma City, OK

    Background/Purpose: Sjogren’s syndrome (SS) is a chronic autoimmune inflammatory disease characterized by impaired function of salivary and lacrimal glands leading to dry mouth and dry…
  • 1
  • 2
  • 3
  • …
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology